Australasian Journal of Dermatology
Издатель: Wiley · ISSN 00048380 · 65 статей
-
Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma: A Narrative Review
ABSTRACT Cutaneous squamous cell carcinoma (cSCC) is a leading cause of cancer‐related morbidity and mortality in solid organ transplant recipients (SOTRs). Immune checkpoint inhibitors (ICIs) targeting programmed death receptor‐1...
-
Incidental Germline EPHB4 Variant in TEK‐Related Venous Malformation
Key Points Next generation sequencing of lesional tissue revealed an unexpected pathogenic EPHB4, subsequently identified as germline, in a child with venous malformation associated with two pathogenic mosaic TEK variants. The findings...
-
Emerging Targeted Therapies in Hidradenitis Suppurativa: A Systematic Review of JAK‐1, IL‐1, and CXCR1/2 Pathway‐Directed Therapies
ABSTRACT Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that may remain inadequately controlled despite established biologic therapies. Emerging therapies targeting JAK‐1, IL‐1 and CXCR1/2 pathways have generated...
-
Sun Exposure Is Associated With the Increase in Skin Cancer Numbers Over Time: The Trends of Skin CAncer Numbers in Solid Organ Transplant Recipients, TOSCANI Longitudinal Cohort Study
ABSTRACT Background/Objectives Solid organ transplant recipients (SOTRs) face an elevated risk of keratinocyte cancers (KCs) due to immunosuppression. Although many studies focused on incidence, the clinical burden of disease may be...
-
Dual Biologic Therapy With Dupilumab and Mepolizumab in Refractory Atopic Dermatitis and Severe Eosinophilic Asthma
Australasian Journal of Dermatology, EarlyView.
-
Burden of Keratinocyte Cancers in Renal Transplant Recipients: A Retrospective Cohort Study
ABSTRACT Objectives Renal transplant recipients (RTRs) are at increased risk of keratinocyte cancer (KC) development due to immunosuppression. A single‐centre retrospective cohort study was conducted to determine the incidence, risk...
-
Acute Cutaneous Kava Toxicity: A Multicentre Case Series From South Australia
ABSTRACT Kava ( piper methysticum ) is a traditional beverage of Pacific Island communities which in 2021, re‐entered the Australian market, primarily promoted as an anxiolytic ‘wellness’ product. Emerging cases of acute kava toxicity...
-
Patch Test Characteristics in Patients With Psoriasis: A Case–Controlled Comparative Study
Australasian Journal of Dermatology, EarlyView.
-
IgG4‐Related Disease: A Diagnostic Dilemma for 20 Years
ABSTRACT We report a case of IgG4‐related disease in a 65‐year‐old man who remained undiagnosed for two decades. His disease initially manifested as periorbital oedema, followed by right cheek swelling, lymphadenopathy and a widespread...
-
Detection of Anti‐IgE Antibodies Against Basement Membrane Zone in Bullous Pemphigoid by Direct Immunofluorescence: Prevalence, Associations and Significance
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e416-e425, November 2026.
-
Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e408-e415, November 2026.
-
Ultrasound‐Guided Skin Biopsy: Application in Diagnosis of Reticulate Eruptions
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 411-413, November 2026.
-
Dermoscopic Features of Mpox: A Case Series
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 406-410, November 2026.
-
Cutaneous Adverse Events in Children Receiving Mitogen‐Activated Protein Kinase Pathway Inhibitors
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 399-405, November 2026.
-
The Prevalence of Adult Atopic Eczema in New Zealand
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 394-398, November 2026.
-
Janus Kinase Inhibitors in Alopecia Areata: Targeted Interruption or Functional Replacement of Systemic Corticosteroids?
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e458-e459, November 2026.
-
Recurrence Rates of Incompletely Excised Primary Basal Cell Carcinoma Treated With Mohs Micrographic Surgery and Radiotherapy
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e456-e457, November 2026.
-
Revisiting the Role of Antibiotics in Hidradenitis Suppurativa in the Biologic Era
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 442-444, November 2026.
-
The Dermatologist's Role in Early PMOS Diagnosis
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 440-441, November 2026.
-
Oral Roflumilast in Lichen Planus: A Prospective Real‐World Case Series of Ten Adults
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e440-e444, November 2026.
-
Patient Acceptability, Perceptions and Concerns Regarding Artificial Intelligence Scribes in Outpatient Dermatology Clinics
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e436-e439, November 2026.
-
Alpelisib for TEK‐ and PIK3CA‐Related Venous Malformations: A Systematic Review
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e426-e430, November 2026.
-
Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 420-423, November 2026.
-
Effect of Anti‐IL‐23 and Anti‐IL‐17 Therapy on Darier Disease: A Case Series
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 414-419, November 2026.
-
Optimising Melanoma Diagnostic Accuracy in Specialised Pigmented Lesion Clinics: A Five‐Year Audit of Number Needed to Treat
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e445-e448, November 2026.
-
Dupilumab‐Associated Erythema Multiforme‐Like Eruption With Lichenoid Histology in a Paediatric Patient: A Case Report
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 424-427, November 2026.
-
Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e431-e435, November 2026.
-
Towards Greater Representation of Diversity in Australian Dermatology Clinical Trials: Current Landscape and Strategies Forward
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 428-433, November 2026.
-
Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service
Australasian Journal of Dermatology, Volume 67, Issue 7, Page e449-e450, November 2026.
-
A Retrospective Review of Scabies Cases Managed by the Dermatology Department in a North Queensland Hospital Over a 10‐Month Period
Australasian Journal of Dermatology, Volume 67, Issue 7, Page 434-436, November 2026.